GTHX DCF Valuation - G1 Therapeutics Inc

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 7.15 USD Market Closed

Market Cap: $377.2m

	G1 Therapeutics Inc NASDAQ:GTHX	US
	Kanemi Co Ltd TSE:2669	JP
X	Xylem Inc LSE:0M29	US
	Alarum Technologies Ltd NASDAQ:ALAR	IL
	Comstock Inc F:GSP	US
	Catering International & Services SA PAR:ALCIS	FR
	GSE Systems Inc NASDAQ:GVP	US
	Meritz Financial Group Inc KRX:138040	KR
	W R Berkley Corp NYSE:WRB	US
N	Norsemont Mining Inc CNSX:NOM	CA
P	Pharmaniaga Bhd KLSE:PHARMA	MY
D	Deutsche Wohnen SE OTC:DWHHF	DE
	Qualicorp Consultoria e Corretora de Seguros SA BOVESPA:QUAL3	BR
	Nestle SA SIX:NESN	CH
C	Cheniere Energy Inc LSE:0HWH	US
	Alamo Group Inc NYSE:ALG	US
L	Leonardo SpA XBER:FMNB	IT
	Telkom Indonesia (Persero) Tbk PT NYSE:TLK	ID
U	UniCredit SpA LSE:0RLS	IT
	Bimobject AB F:BOJB	SE
M	Microsoft Corp MIL:MSFT	US
C	CompuGroup Medical SE & Co KgaA LSE:0MSD	DE
A	Anglo American PLC OTC:AAUKF	UK

GTHX's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.